Skip to main content
. 2020 Feb 4;20:30. doi: 10.1186/s12876-020-1180-0

Table 1.

Baseline characteristics of the patients and laboratory tests

Variables PAs-HSOS BCS P
Erythrocytes, 1012/L 5.00 ± 4.33 4.33 ± 0.84 0.053
Hemoglobin, g/L 135.99 ± 26.81 128.11 ± 24.00 0.061
Leukocyte, 109/L 6.90 ± 2.81 4.87 ± 2.59 <0.001
Platelet, 109/L 114.06 ± 63.48 119.37 ± 83.98 0.651
ALT, U/L 134.5 ± 154.89 40.60 ± 64.75 0.002
AST, U/L 146.31 ± 156.30 49.72 ± 54.81 0.001
ALP, U/L 170 ± 106.89 122.25 ± 69.08 0.003
γ-GT, U/L 160.52 ± 114.56 106.60 ± 85.94 0.002
T-BIL, μmol/L 65.07 ± 78.83 35.58 ± 28.47 0.001
Albumin, g/L 30.71 ± 5.50 35.51 ± 6.29 <0.001
PT, S 17.43 ± 2.64 15.63 ± 2.01 <0.001
Urea, mmol/L 7.19 ± 3.63 5.26 ± 2.76 0.001
Cr, μmol/L 90.65 ± 45.61 64.16 ± 18.67 <0.001

Note: Baseline characteristics of PAs-induced HSOS refer to initial examination during first visit to our hospitals. PAs-HSOS PAs-induced HSOS; BCS Budd-Chiari syndrome; normal ranges: erythrocytes: 3.0–5.5 × 1012/L; hemoglobin: 110–160 g/L; leukocyte: 4–10 × 109 /L; platelet: 100–300 × 109/L; alanine aminotransferase: 5–35 U/L; aspartate aminotransferase (AST):8-40 U/L; alkaline phosphatase (ALP) 40–150 U/L; total bilirubin (T-BIL): 5.1–19 μmol/L; γ-glutamyl transpeptidase (γ-GT) 7–32 U/L; albumin: 35-55 g/L; prothrombin time (PT): 11–16 S; urea: 3.2–7.1 mmol/L; creatinine (Cr): 44–106 μmol/L.